Research & Markets: Global Bare Metal Stents Market 2011-2015: Abbott Laboratories, Medtronic Inc., Cordis Corp., & Boston Sc...

Date : 06/29/2012 @ 11:27AM
Source : Business Wire

Research & Markets: Global Bare Metal Stents Market 2011-2015: Abbott Laboratories, Medtronic Inc., Cordis Corp., & Boston Sc...

Research and Markets ( has announced the addition of the "Global Bare Metal Stents Market 2011-2015" report to their offering.

TechNavio's analysts forecast the Global Bare Metal Stents market to reach US$1.86 billion by 2015. One of the key factors contributing to this market growth is the high prevalence of cardiovascular diseases. The Global Bare Metal Stents market has also been witnessing the trend of increasing demand for minimally invasive procedures. However, the presence of alternative coronary stents could pose a challenge to the growth of this market.

This report has been prepared based on an in-depth analysis of the market with inputs from industry experts. The report covers the Americas, and the EMEA and APAC regions; it also covers the Global Bare Metal Stents market landscape and its growth prospects in the coming years. The report also includes a discussion of the key vendors operating in this market.

Key vendors dominating this market space include: Abbott Laboratories, Medtronic Inc., Cordis Corp., and Boston Scientific Corp. Other vendors mentioned in the report: Microport Scientific Corp., Cook Medical, Biosensors International Ltd., B. Braun Melsungen AG.

Key questions answered in this report:

- What will the market size be in 2015 and at what rate will it grow?

- What key trends is this market subject to?

- What is driving this market?

- What are the challenges to market growth?

- Who are the key vendors in this market space?

- What are the opportunities and threats faced by each of these key vendors?

- What are the strengths and weaknesses of each of these key vendors?

- You can request one free hour of analyst time when you purchase this report. Details provided within the report.

Executive Summary

Commenting on the report, an analyst from TechNavio's Healthcare team said; The development of new alloys for the manufacture of coronary stents is expected to lead to an increase in the adoption of Bare Metal Stents (BMSs) in the treatment of coronary heart disease (CHD). The usage of new alloys such as cobalt-chromium (CoCr) and platinum-chromium (PtCr) has led to the design and manufacture of advanced stents. Traditionally, stainless steel was used in the production of BMSs. Though flexibility and deliverability were achieved with the use of stainless steel, there was a loss of radiopacity and compression strength. These drawbacks were overcome through the use of CoCr stents, which enabled manufacturers to design stents with even thinner struts than before. This technological advancement will help drive the growth of the Global BMS market.

According to the report, globally, cardiovascular diseases (CVDs) such as CHD and strokes are on the rise. The increase in the incidence of CVD is due to a variety of factors, such as obesity, diabetes, excessive smoking and alcohol consumption, and unhealthy lifestyles. Further, the rapidly increasing aging population is increasing the number of people prone to CVD. All these factors drive the demand in the Global BMS market.

Key Topics Covered:

01. Executive Summary

02. Introduction

03. Market Coverage

04. Market Landscape

05. Geographical Segmentation

06. Key Leading Countries

07. Rate of Incidence and Prevalence

08. Vendor Landscape

09. Buying Criteria

10. Market Growth Drivers

11. Drivers and their Impact

12. Market Challenges

13. Impact of Drivers and Challenges

14. Market Trends

15. Key Vendor Analysis

15.1 Abbott Laboratories

15.2 Medtronic Inc.

15.3 Cordis Corp.

15.4 Boston Scientific Corp.

16. Other Reports in this Series

For more information visit

Your Recent History
Gulf Keyst..
FTSE 100
UK Sterlin..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.

NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P:43 V:us D:20180317 20:14:35